| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Mar 16, 2024 | Mar 25, 2024 | Axogen, Inc. | Chief R&D Officer | Sell | 42.5 | -6,881 | -3.96% | ✗ | $52.8K |
| Jul 18, 2023 | Oct 13, 2023 | Axogen, Inc. | Chief R&D Officer | Sell | 82.5 | +1,168 | 3.26% | ✗ | $5.7K |
| Mar 16, 2023 | Mar 20, 2023 | Axogen, Inc. | Chief R&D Officer | Sell | 46.3 | -3,907 | -9.84% | ✗ | $32.3K |
| Dec 27, 2022 | Dec 29, 2022 | Axogen, Inc. | Chief R&D Officer | Sell | 47.5 | -286 | -1.09% | ✗ | $2.7K |
| Jul 18, 2022 | Jul 20, 2022 | Axogen, Inc. | Chief R&D Officer | Sell | 82.5 | +1,914 | 4.17% | ✗ | $5.5K |
| Mar 16, 2022 | Mar 18, 2022 | Axogen, Inc. | Chief R&D Officer | Sell | 46.3 | -2,770 | -12.07% | ✗ | $22.1K |
| Feb 15, 2022 | Feb 17, 2022 | Axogen, Inc. | Chief R&D Officer | Sell | 85.0 | +925 | 8.39% | ✗ | $3.4K |
| Dec 27, 2021 | Dec 29, 2021 | Axogen, Inc. | Chief R&D Officer | Sell | 47.5 | -286 | -2.54% | ✗ | $2.8K |
| Jul 19, 2021 | Jul 21, 2021 | Axogen, Inc. | Chief R&D Officer | Sell | 91.3 | +1,935 | 23.64% | ✗ | $12.2K |
| Feb 16, 2021 | Feb 18, 2021 | Axogen, Inc. | Chief R&D Officer | Sell | 90.0 | +919 | 15.00% | ✗ | $7.6K |
| Dec 27, 2020 | Dec 30, 2020 | Axogen, Inc. | VP Research & Development | Sell | 91.3 | +1,733 | 45.65% | ✗ | $10.1K |
| Feb 18, 2020 | Feb 20, 2020 | Axogen, Inc. | VP Research & Development | Sell | 90.0 | +932 | 70.77% | ✗ | $5.8K |